Farallon Capital Management LLC Galapagos Nv Transaction History

Farallon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$88.4 - $105.34 $27.3 Million - $32.5 Million	-308,260 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$94.51 - $120.23 $1.73 Million - $2.2 Million	18,260 Added 6.3%	308,260 $30.8 Million
Q4 2017 Feb 14, 2018	BUY	$84.48 - $104.02 $4.54 Million - $5.59 Million	53,784 Added 22.77%	290,000 $27.2 Million
Q3 2017 Nov 14, 2017	BUY	$73.17 - $103.47 $17.3 Million - $24.4 Million	236,216	236,216 $24 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.79B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.